Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C... Show more
Bath & Body Works (BBWI) stock has navigated choppy waters in recent trading sessions, hovering around the lower end of its 52-week range amid broader retail sector pressures. The shares reflect investor caution over discretionary spending trends, yet maintain a compelling valuation with a forward P/E (price-to-earnings ratio, a measure of stock price relative to expected earnings) below 7 and a robust dividend payout. Recent weeks have seen modest rebounds tied to strategic announcements, underscoring resilience in core fragrance and body care demand. As the company advances its Consumer First Formula—focusing on innovation and marketplace expansion—traders eye upcoming quarterly results for signs of stabilization in comparable sales and margin recovery.
Tickeron’s Trending AI Robots page curates the top-performing AI-driven trading bots from its library of over 350 advanced agents, spotlighting around 25 elite performers best aligned with prevailing market dynamics. These bots leverage machine learning for real-time signals across stocks, ETFs, and crypto, employing diverse strategies like trend-following, volatility plays, and sector rotations with timeframes from intraday to multi-week holds. Standout stats include annualized returns spanning 23% to over 285%—such as a Space Infrastructure bot at +285% with a 72% win rate—and win rates commonly between 70% and 88%, with profit factors up to 4.19. Covering high-growth areas like semiconductors, industrials, and data centers, they demonstrate superior risk-adjusted performance versus benchmarks like the S&P 500. Traders can explore these for automated, data-backed entries tailored to current conditions. Visit the Trending AI Robots page to evaluate options suited to your portfolio.
Bath & Body Works (BBWI) has faced heightened scrutiny in recent weeks as it executes a multi-faceted turnaround amid challenging retail dynamics. A pivotal move came around late April with the appointment of Veronique Gabai-Pinsky as the company's first-ever chief brand and product officer, effective May 18. This leadership addition, building on her prior advisory role, is tasked with spearheading brand elevation, creative direction, and product innovation—core pillars of the Consumer First Formula strategy. Investors viewed this positively as a signal of commitment to refreshing assortments and capturing younger demographics, contributing to modest share gains amid broader market volatility.
Product launches have further fueled sentiment. Early May saw the debut of an exclusive Star Wars: The Mandalorian and Grogu collection, timed with the film's theatrical release on May 22. This out-of-this-world fragrance and body care line exemplifies selective collaborations aimed at driving foot traffic and digital buzz, helping offset softer core category demand. Such experiential tie-ins have historically lifted seasonal sales, providing a counterbalance to macroeconomic headwinds like persistent inflation curbing discretionary buys.
Earlier Q4 fiscal 2025 results (reported in March, influencing ongoing trading) showed net sales of $2.7 billion, down 2.3% year-over-year but beating lowered expectations, with adjusted EPS of $2.05 topping consensus by 17%. Full-year sales held flat at $7.3 billion, but 2026 guidance tempered optimism: net sales projected down 2.5% to 4.5%, adjusted EPS $2.40-$2.65 (versus $3.21 prior year), framing the period as an "investment year" for transformation. This outlook, coupled with tariff headwinds (about 150 basis points impact on Q1 gross margins) and sales deleverage, pressured shares initially, though director buying signaled internal confidence.
Analyst reactions post-earnings were mixed: Telsey Advisory, Barclays, and others raised targets to $25 (from $21-23), while maintaining "Hold" ratings; consensus target now ~$27.60 implies ~40% upside. Competitive notes emerged, with Victoria's Secret eyeing fragrance expansion into BBWI turf, potentially intensifying rivalry. Legal overhangs, including a securities class action probe alleging misleading growth strategy disclosures (filed around mid-April), added noise but haven't derailed momentum. Price action reflects these cross-currents: shares dipped to ~$18.30 lows before rebounding toward $19.70s on positive news flow, with elevated volume underscoring event-driven trading. Q1 earnings on May 27 loom large for updates on early strategy traction.
As Bath & Body Works navigates fiscal 2026, focus remains on the Consumer First Formula's execution amid guided sales declines of 2.5%-4.5% and adjusted EPS of $2.40-$2.65. Investors should track progress in core areas: innovation via elevated fragrances and collaborations, brand refresh under new leadership, and marketplace expansion including Amazon partnerships to diversify beyond ~1,000 U.S. stores. Free cash flow outlook of ~$600 million supports $0.80 dividend continuity and selective capex (~$270 million) in logistics and real estate, targeting 1% square footage growth.
Risks include sustained tariff pressures (BPS headwinds on margins), B&O (buying and occupancy costs, fixed store expenses) deleverage from sales softness, and discretionary spending sensitivity in a high-interest environment. Opportunities lie in international growth (573 doors) and digital acceleration, potentially stabilizing comps into 2027. Competitive positioning versus peers like Victoria's Secret, alongside Q1 results on May 27, will gauge if transformation yields early wins in customer acquisition and loyalty.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
The Moving Average Convergence Divergence (MACD) for BBWI turned positive on May 07, 2026. Looking at past instances where BBWI's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 64 cases where BBWI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
BBWI moved above its 50-day moving average on May 08, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BBWI advanced for three days, in of 281 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 159 cases where BBWI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Momentum Indicator moved below the 0 level on May 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BBWI as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BBWI declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BBWI broke above its upper Bollinger Band on April 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (4.278). P/E Ratio (6.344) is within average values for comparable stocks, (43.361). Projected Growth (PEG Ratio) (0.866) is also within normal values, averaging (1.383). Dividend Yield (0.041) settles around the average of (0.030) among similar stocks. P/S Ratio (0.566) is also within normal values, averaging (4.684).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BBWI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BBWI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an operator of retail business
Industry SpecialtyStores